Seth Smith, Ph.D., an MRI expert and now an AIMBE fellow, has refined imaging capabilities to improve diagnosis of MS and other diseases.
Characterizing molecular tissue may provide insight into new treatments for high-risk AMD factors.
Early identification and management of visual disorders may mitigate negative effects, according to Vanderbilt co-author.
Study finds the condition can develop after COVID-19 in patients lacking predisposing conditions, but cases are rare and visual outcomes are good.
New techniques are eradicating tumors and preserving vision for pediatric patients with retinoblastoma.
A cytokine that acts as an antioxidant proves neuroprotective against ocular injury.
1 / 5
New studies explore advances in standard and immunosuppressive therapies.
Clinical trial results suggest new therapies could restore vision lost to LHON.
Monoclonal antibody is promising treatment for disabling autoimmune disorder.